Recruiting

Dexcom Continuous Glucose Monitoring System Data Collection

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
Study Aim

This study aims to observe and collect data on patient experiences using the Dexcom Continuous Glucose Monitoring System over four years.

What is being collected

Data Collection

Collected from today forward - Prospective
Who is being recruted

Diabetes Mellitus+2

+ Endocrine System Diseases

+ Metabolic Diseases

Over 2 Years
+9 Eligibility Criteria
See all eligibility criteria
How is the trial designed

Cohort

Tracking disease incidence in order to identify risk factors and understand disease progression over time.
Observational
Study Start: February 2024
See protocol details

Summary

Principal SponsorDexCom, Inc.
Study ContactStayce Beck, PhDMore contacts
Last updated: January 28, 2026
Sourced from a government-validated database.Claim as a partner

Study start date: February 28, 2024

Actual date on which the first participant was enrolled.

"The Dexcom Global Registry is a non-randomized, open-label, multi-center registry with the goal of collecting Dexcom CGM System data in a real world setting.The registry study involves retrospective and/or prospective data collection associated with Dexcom CGM System use."

Official TitleDexcom Continuous Glucose Monitoring System Use in aReal-World, Global Registry
NCT06483945
Principal SponsorDexCom, Inc.
Study ContactStayce Beck, PhDMore contacts
Last updated: January 28, 2026
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

5000 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Cohort

These studies follow a group of individuals with common characteristics (such as a condition or birth year) over a specific period to study health outcomes or exposures.

Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

Over 2 Years

Range of ages for which participants are eligible to join.

Healthy volunteers allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

Diabetes MellitusEndocrine System DiseasesMetabolic DiseasesNutritional and Metabolic DiseasesGlucose Metabolism Disorders

Criteria

7 inclusion criteria required to participate
Meets Dexcom CGM System Indications for Use (IFU) per approved commercial labeling
Has at least one HbA1C (Hemoglobin a1c) measurement within three (3) months prior to the Dexcom CGM System use start date that is at least three (3) months after any prior CGM use
Subject is willing and able to use Dexcom CGM System according to approved product labeling
Subject is willing and able to complete applicable patient reported outcome assessments/ surveys
Show More Criteria
2 exclusion criteria prevent from participating
Is contraindicated for a Dexcom CGM System per approved commercial labeling
In the Investigator's opinion, the subject is not considered to be a suitable candidate

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Study Objectives

Study Objectives

Primary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 2 locations

Recruiting

Institute of Endocrinology Diabetes, Health & Hormones

Stockbridge, United StatesOpen Institute of Endocrinology Diabetes, Health & Hormones in Google Maps
Recruiting

Palm Research Center

Las Vegas, United States
Recruiting
2 Study Centers